Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotype-guided low-dose efavirenz in Chinese adults with HIV
ChiCTR-IOR-15007465Phase 4Recruiting
- Sponsor
- School of Pharmacy, Chinese University of Hong Kong
- Start
- Jan 1990
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of efavirenz in human immunodeficiency virus infection (HIV) (2 arms), sponsored by School of Pharmacy, Chinese University of Hong Kong. Primary endpoint: Proportion of subjects with sufficient viral suppression. Started Jan 1990; status: recruiting.
02
Drugs
efavirenz
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on ChiCTR-IOR-15007465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IOR-15007465.